UPDATE : Saturday, February 22, 2020
Pfizer wins Champix patent suit against 20 local generics makers by Jeong Sae-im 2019-12-20 16:28
Chemas to research anticancer treatment in Germany by Lee Han-soo 2019-12-20 15:18
Bridge Biotherapeutics seeks IND status for lung cancer treatment by Lee Han-soo 2019-12-20 14:41
Boehringer Ingelheim stops developing Pharmaxis’ NASH treatment candidate by Lee Han-soo 2019-12-19 17:42
AstraZeneca, Korean partners launch joint project to accelerate bio-health innovation by Lee Han-soo 2019-12-19 17:40
AstraZeneca, SK Holdings celebrates manufacturing partnership by Lee Han-soo 2019-12-19 16:39
Daewoong wins sales approval for Nabota in UAE, Indonesia by Lee Han-soo 2019-12-19 12:09
Crystal Genomics acquires Hwail as subsidiary by Lee Han-soo 2019-12-18 17:48
4 new botulinum toxins to undergo trials in crowded market by Jeong Sae-im 2019-12-18 15:29
‘Roche's Xofluza to revolutionize influenza antivirals’ by Lee Han-soo 2019-12-17 16:30
Novartis reaffirms efficacy of Tasigna in treating chronic myelogenous leukemia by Lee Han-soo 2019-12-17 14:48
CDK4/6+fulvestrant combo may get benefit in 1st half of 2020 by Kim Yun-mi 2019-12-17 11:59
CJ Healthcare unites with Standigm to develop AI-based anticancer drugs by Lee Han-soo 2019-12-17 11:58
Dong-A, Meiji Seika to conduct P1 trial for Stelara biosimilar by Lee Han-soo 2019-12-16 17:01
Huons Lab, Pangen to codevelop human genetic recombinant hyaluronidase by Lee Han-soo 2019-12-16 15:23
KDA tells patients not to stop taking metformin arbitrarily by Lee Han-soo 2019-12-16 10:56
GC, Add Pharma to co-develop synthetic drugs by Lee Han-soo 2019-12-13 16:25
Daewoong releases trial results for autoimmune disease treatment candidate by Lee Han-soo 2019-12-13 15:12
GC Labcell releases trial results of NK-cell combination treatment by Lee Han-soo 2019-12-12 18:00
Eli Lilly Korea launches migraine prevention drug by Lee Han-soo 2019-12-12 15:28
Back to Top